Form 8-K · Current Report · Filed 2024-10-30
GE HealthCare Technologies Realigns Reportable Segments
GE HealthCare Technologies Inc. announced a realignment of its reportable segments effective July 1, 2024, as disclosed under Item 7.01. The Image Guided Therapies (IGT) segment was moved from the Imaging segment to the Ultrasound segment, which was renamed to Advanced Visualization Solutions (AVS). This realignment better matches clinical usage and aims to enhance business and customer impact. The Company continues to operate four reportable segments: Imaging, AVS, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Recast unaudited historical financial information reflecting the new segment structure is provided in Exhibit 99, which is not included in this filing but referenced for comparability purposes.
- Filer
- Ge Healthcare Technologies Inc. GEHC · NASDAQ
- Filed
- Accession
- 0001932393-24-000051
- CIK
- 0001932393
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Regulation FD Disclosure
Financial Statements and Exhibits
Market reaction
Close before filing
$85.27
Next session
+2.4%
Since filing
-20.2%
Latest close
$68.02
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from GEHC reporting the same item, with the next session's move:
Exhibits (1)
About Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc. is a prominent player in the healthcare industry, focused on providing transformative medical technology and diagnostic solutions. Specializing in imaging, monitoring, and diagnostic equipment, the company plays a crucial role in enhancing clinical outcomes, improving patient care, and driving medical technology innovations. Ge Healthcare Technologies Inc. is recognized for its advancements in medical imaging systems, including MRI, CT, and ultrasound technologies, which aid in early disease detection and treatment planning. In addition to its hardware innovations, the company is actively involved in digital healthcare solutions, employing data analytics and AI to support precise diagnoses and personalized medicine. The impact of Ge Healthcare Technologies extends across various healthcare sectors, including hospitals, clinics, and research institutions, underscoring its importance in advancing clinical capabilities and operational efficiencies within the healthcare system. Ge Healthcare Technologies Inc. maintains a strategic presence in global markets, bolstering healthcare infrastructure and supporting public health initiatives. By continuously striving to innovate and improve healthcare delivery, it remains a significant entity within the broader medical technology and life sciences industry, contributing to the future of healthcare.
Never miss another GEHC filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.